Securecell supports CGT Catapult's Numera and Lucullus lab platform
- Cell and Gene Therapy Catapult
- Direct award
- 31 July 2026 to 30 July 2027
Cell and Gene Therapy Catapult turned to Securecell AG - BPES for support on its Numera and Lucullus lab automation platform. The Catapult bought the platform, which pairs the Numera automatic sampling system with Lucullus software, over 2022/2023. That purchase was set at £590,149 over five years, and spending with the supplier was nearing that sum.
A new direct award keeps hardware and software support in place under a service level agreement. The supplier is the only provider of the platform, and no other firm is expected to offer the support the Catapult needs. The £650,792 contract was awarded in June 2026 and runs to July 2027.
Contract ends July 2027
- What
- Laboratory informatics and instrument software
- Supplier
- Securecell AG - BPES
- Value
- £650,792
- How it was bought
- Direct award
- Dates and next
- Jul 2026 to Jul 2027